ovarian cancer
Mayo Clinic researchers are studying the cost-effectiveness of genomic research to detect certain diseases earlier, including breast, ovarian and colorectal cancer.
Gynecologic surgeon Dr. Tri Dinh explains why ovarian cancer is hard to detect, options for reducing ovarian cancer risk, and how the disease is treated.
Mayo Clinic is sequencing the exomes of tens of thousands of people from diverse backgrounds to investigate large-scale patterns of distinctive mutations that fuel disease.
Physician assistant Casey Swanson responds to a question about cancer risk and genetic testing for a BRCA2 mutation.